array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Bio-RAD Laboratories, Inc." ["slug"]=> string(33) "001cd-us-bio-rad-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920" ["description"]=> string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together. #Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics" ["address_street"]=> string(20) "1000 Alfred Nobel Dr" ["address_place"]=> string(8) "Hercules" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1952-02-08" ["website_domain"]=> string(11) "bio-rad.com" ["website_url"]=> string(23) "https://www.bio-rad.com" ["industry_codes"]=> array(3) { [0]=> string(42) "In Vitro and In Vivo Diagnostic Substances" [1]=> string(33) "Laboratory Analytical Instruments" [2]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(7900) ["article_count"]=> int(661) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(95) "American Century Companies Inc. Acquires 34,008 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)" ["snippet_en"]=> string(231) "American Century Companies Inc. grew its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 261.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission." ["url"]=> string(132) "http://www.defenseworld.net/2023/08/31/american-century-companies-inc-acquires-34008-shares-of-bio-rad-laboratories-inc-nysebio.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/6d5bd8ea-cdf3-4c11-9ab8-b487869e91d0" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-08-31" ["categories"]=> array(8) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(13) "Credit Rating" [2]=> string(12) "Stock Market" [3]=> string(18) "General Investment" [4]=> string(24) "Quarterly/Annual Figures" [5]=> string(11) "Acquisition" [6]=> string(14) "Issuing Shares" [7]=> string(24) "Stock Research & Ratings" } } [1]=> array(7) { ["title_en"]=> string(77) "Libra Wealth LLC Acquires Shares of 445 Bio-Rad Laboratories, Inc. (NYSE:BIO)" ["snippet_en"]=> string(299) "Libra Wealth LLC bought a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 445 shares of the medical research company's stock," ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-bio-sec-filing-2023-07-21/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/55b9d9b8-a0e6-4b1f-96b6-eed09e498f14" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2023-07-21" ["categories"]=> array(6) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(12) "Stock Market" [2]=> string(11) "Acquisition" [3]=> string(11) "Regulations" [4]=> string(14) "Issuing Shares" [5]=> string(24) "Stock Research & Ratings" } } [2]=> array(7) { ["title_en"]=> string(91) "102 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Acquired by Romano Brothers AND Company" ["snippet_en"]=> string(195) "Romano Brothers AND Company acquired a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) during the 4th quarter, according to its most recent disclosure with the SEC." ["url"]=> string(131) "https://www.defenseworld.net/2023/03/28/102-shares-in-bio-rad-laboratories-inc-nysebio-acquired-by-romano-brothers-and-company.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2a3faf0c-facb-4a98-9f98-e436c56283b6" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-03-28" ["categories"]=> array(3) { [0]=> string(14) "Issuing Shares" [1]=> string(18) "General Investment" [2]=> string(11) "Acquisition" } } [3]=> array(7) { ["title_en"]=> string(78) "Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Allworth Financial LP" ["snippet_en"]=> string(184) "Allworth Financial LP increased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 414.8% in the 3rd quarter, according to its most recent 13F filing with the SEC." ["url"]=> string(109) "https://reporter.am/2023/01/01/bio-rad-laboratories-inc-nysebio-shares-acquired-by-allworth-financial-lp.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/91096d8a-94eb-4cb2-bfd5-836a2e84a7e7" ["source"]=> string(11) "reporter.am" ["publication_date"]=> string(10) "2023-01-01" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(14) "Issuing Shares" [2]=> string(11) "Acquisition" } } [4]=> array(7) { ["title_en"]=> string(54) "Bio-Rad acquires Curiosity Diagnostics for up to $170M" ["snippet_en"]=> string(126) "Bio-Rad will gain Curiosity Diagnostics' PCR|One platform, a sample-to-answer, rapid diagnostics PCR system under development." ["url"]=> string(81) "https://www.massdevice.com/bio-rad-acquires-curiosity-diagnostics-for-up-to-170m/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/1a4c79a6-2021-4597-a154-a77d6a43a927" ["source"]=> string(14) "massdevice.com" ["publication_date"]=> string(10) "2022-08-04" ["categories"]=> array(3) { [0]=> string(23) "Supply Chain Disruption" [1]=> string(18) "General Investment" [2]=> string(11) "Acquisition" } } [5]=> array(7) { ["title_en"]=> string(38) "Bio-Rad Acquires Curiosity Diagnostics" ["snippet_en"]=> string(150) "Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it ha" ["url"]=> string(95) "https://www.businesswire.com/news/home/20220803005823/en/Bio-Rad-Acquires-Curiosity-Diagnostics" ["image_url"]=> string(78) "https://images.businessradar.com/articles/14941ac0-5ac2-4025-a0d2-da26827cc02b" ["source"]=> string(16) "businesswire.com" ["publication_date"]=> string(10) "2022-08-03" ["categories"]=> array(2) { [0]=> string(5) "SPACs" [1]=> string(11) "Acquisition" } } [6]=> array(7) { ["title_en"]=> string(184) "Bio-Rad Laboratories, Inc.. (8/3/22). "Press Release: Bio-Rad Acquires Curiosity Diagnostics". Hercules, CA. - [LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal" ["snippet_en"]=> string(83) "Life Sciences Business Intelligence Web Portal for North America, Europe and Israel" ["url"]=> string(115) "https://www.life-sciences-usa.com/news/bio-rad-acquires-curiosity-diagnostics-group-scope-fluidics-2001-120312.html" ["image_url"]=> NULL ["source"]=> string(21) "life-sciences-usa.com" ["publication_date"]=> string(10) "2022-08-03" ["categories"]=> array(1) { [0]=> string(11) "Acquisition" } } [7]=> array(7) { ["title_en"]=> string(85) "Machina Capital S.A.S. Acquires New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)" ["snippet_en"]=> string(192) "Machina Capital S.A.S. acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) during the 1st quarter, according to its most recent Form 13F filing with the SEC." ["url"]=> string(115) "https://reporter.am/2022/07/10/machina-capital-s-a-s-acquires-new-position-in-bio-rad-laboratories-inc-nysebio.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b11b3ff7-58ff-41ef-8cc6-f8aebc668ddf" ["source"]=> string(11) "reporter.am" ["publication_date"]=> string(10) "2022-07-10" ["categories"]=> array(1) { [0]=> string(11) "Acquisition" } } [8]=> array(7) { ["title_en"]=> string(38) "Bio-Rad Acquires Curiosity Diagnostics" ["snippet_en"]=> string(249) "Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o." ["url"]=> string(114) "https://investors.bio-rad.com/press-releases/news-details/2022/Bio-Rad-Acquires-Curiosity-Diagnostics/default.aspx" ["image_url"]=> NULL ["source"]=> string(11) "bio-rad.com" ["publication_date"]=> string(10) "2022-02-09" ["categories"]=> array(1) { [0]=> string(11) "Acquisition" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(66) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(51) } [2]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(31) } [3]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(28) } [4]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(26) } [5]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(23) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(20) } [8]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(19) } [9]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(19) } [11]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(18) } [12]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [14]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(13) } [15]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(13) } [16]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(9) } [19]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [20]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(8) } [21]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(7) } [24]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(7) } [25]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(15) "Business Ethics" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(5) } } } 001cd-us-bio-rad-laboratories-inc